AIMS: To explore views on the ideal structure and process of support groups for cancer patients. PATIENTS AND METHODS: From 184 cancer support groups identified in NSW, Australia, 50 were randomly selected within strata of five variations in group structure: homogenous versus heterogenous participants; urban versus rural; community versus hospital setting, leader with cancer experience or not; and with professional training or not. Four hundred and seventy-six group members completed a questionnaire. RESULTS: Participants valued being with others like them, gaining information about cancer and having an effective leader. Groups were seen to be currently failing people from culturally and linguistically diverse backgrounds, and links with oncology health professionals were inadequate. Few clear preferences for structure were expressed, except for the non-exclusion of those with a poor prognosis. Patients tended to prefer the structure of their own group, but patients longer since diagnosis, those with better informal support and carers preferred to meet in the community setting, while men with prostate cancer preferred a medical setting. CONCLUSIONS: Some suggestions for group structure and process can be made on the basis of these findings; however, individual variation suggests that a needs analysis should be made by individual groups.
AIMS: To explore views on the ideal structure and process of support groups for cancerpatients. PATIENTS AND METHODS: From 184 cancer support groups identified in NSW, Australia, 50 were randomly selected within strata of five variations in group structure: homogenous versus heterogenous participants; urban versus rural; community versus hospital setting, leader with cancer experience or not; and with professional training or not. Four hundred and seventy-six group members completed a questionnaire. RESULTS:Participants valued being with others like them, gaining information about cancer and having an effective leader. Groups were seen to be currently failing people from culturally and linguistically diverse backgrounds, and links with oncology health professionals were inadequate. Few clear preferences for structure were expressed, except for the non-exclusion of those with a poor prognosis. Patients tended to prefer the structure of their own group, but patients longer since diagnosis, those with better informal support and carers preferred to meet in the community setting, while men with prostate cancer preferred a medical setting. CONCLUSIONS: Some suggestions for group structure and process can be made on the basis of these findings; however, individual variation suggests that a needs analysis should be made by individual groups.
Authors: Ursula M Sansom-Daly; Claire E Wakefield; Sarah J Ellis; Brittany C McGill; Mark W Donoghoe; Phyllis Butow; Richard A Bryant; Susan M Sawyer; Pandora Patterson; Antoinette Anazodo; Megan Plaster; Kate Thompson; Lucy Holland; Michael Osborn; Fiona Maguire; Catherine O'Dwyer; Richard De Abreu Lourenco; Richard J Cohn Journal: Cancers (Basel) Date: 2021-05-18 Impact factor: 6.639
Authors: Ursula M Sansom-Daly; Claire E Wakefield; Richard A Bryant; Phyllis Butow; Susan Sawyer; Pandora Patterson; Antoinette Anazodo; Kate Thompson; Richard J Cohn Journal: BMC Cancer Date: 2012-08-03 Impact factor: 4.430
Authors: Hilary L Bekker; Anna E Winterbottom; Phyllis Butow; Amanda J Dillard; Deb Feldman-Stewart; Floyd J Fowler; Maria L Jibaja-Weiss; Victoria A Shaffer; Robert J Volk Journal: BMC Med Inform Decis Mak Date: 2013-11-29 Impact factor: 2.796